| Primary |
| Urinary Tract Infection |
51.5% |
| Product Used For Unknown Indication |
23.6% |
| Atrial Fibrillation |
2.5% |
| Deep Vein Thrombosis |
2.1% |
| Infection |
2.1% |
| Pulmonary Embolism |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Type 2 Diabetes Mellitus |
1.8% |
| Cystitis |
1.4% |
| Lower Respiratory Tract Infection |
1.4% |
| Drug Use For Unknown Indication |
1.2% |
| Hypertension |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Wound Infection Staphylococcal |
1.2% |
| Pain |
0.9% |
| Prophylaxis |
0.9% |
| Prophylaxis Urinary Tract Infection |
0.9% |
| Acne |
0.7% |
| Atrophic Vulvovaginitis |
0.7% |
| Benign Prostatic Hyperplasia |
0.7% |
|
| Tremor |
9.7% |
| Rash |
9.0% |
| White Blood Cell Count Increased |
8.2% |
| Renal Failure Acute |
7.5% |
| International Normalised Ratio Increased |
6.7% |
| Pancytopenia |
6.7% |
| Vomiting |
6.7% |
| Renal Impairment |
6.0% |
| Urticaria |
4.5% |
| Drug Hypersensitivity |
3.7% |
| Dyspnoea |
3.7% |
| Sepsis |
3.7% |
| Convulsion |
3.0% |
| Drug Exposure During Pregnancy |
3.0% |
| Hypoglycaemia |
3.0% |
| Nausea |
3.0% |
| Rash Pruritic |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| Tubulointerstitial Nephritis |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
38.3% |
| Urinary Tract Infection |
14.2% |
| Drug Use For Unknown Indication |
10.6% |
| Drug Abuse |
7.9% |
| Burkitt's Lymphoma |
4.1% |
| Hypertension |
3.8% |
| Schizophrenia |
2.6% |
| Lower Respiratory Tract Infection |
2.3% |
| Prophylaxis |
2.3% |
| Agitation |
1.6% |
| Opportunistic Infection Prophylaxis |
1.4% |
| Acarodermatitis |
1.3% |
| Antifungal Prophylaxis |
1.3% |
| Staphylococcal Infection |
1.3% |
| Cardiovascular Event Prophylaxis |
1.2% |
| Hiv Infection |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Prostatitis |
1.2% |
| Mantle Cell Lymphoma |
1.1% |
| Atrial Fibrillation |
1.0% |
|
| White Blood Cell Count Increased |
15.9% |
| Urinary Tract Infection |
13.6% |
| Weight Decreased |
7.8% |
| Renal Impairment |
6.2% |
| Vomiting |
6.2% |
| Drug Interaction |
5.2% |
| Ventricular Extrasystoles |
4.9% |
| Sepsis |
4.5% |
| Clostridium Test Positive |
4.2% |
| International Normalised Ratio Increased |
4.2% |
| Diarrhoea |
3.9% |
| Acquired Haemophilia |
2.9% |
| Clostridium Difficile Infection |
2.9% |
| Porphyria Acute |
2.9% |
| Toxicity To Various Agents |
2.9% |
| Spinal Fracture |
2.6% |
| Cytolytic Hepatitis |
2.3% |
| Drug Hypersensitivity |
2.3% |
| Malaise |
2.3% |
| Nausea |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.7% |
| Drug Use For Unknown Indication |
8.7% |
| Prophylaxis |
7.3% |
| Urinary Tract Infection |
5.9% |
| Pain |
2.8% |
| Premedication |
2.8% |
| Hiv Infection |
2.6% |
| Hypertension |
2.4% |
| Depression |
2.4% |
| Multiple Myeloma |
2.1% |
| Immunosuppression |
1.9% |
| Muscle Spasms |
1.8% |
| B-cell Lymphoma |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.5% |
| Cardiac Disorder |
1.5% |
| Atrial Fibrillation |
1.3% |
| Infection Prophylaxis |
1.2% |
| Constipation |
1.2% |
| Renal Transplant |
1.2% |
| Nausea |
1.1% |
|
| Vomiting |
13.4% |
| Urinary Tract Infection |
10.3% |
| Weight Increased |
10.3% |
| Weight Decreased |
7.0% |
| Death |
6.2% |
| Rhabdomyolysis |
6.1% |
| Sepsis |
5.0% |
| Tremor |
4.5% |
| Pyrexia |
4.3% |
| Urticaria |
3.6% |
| Thrombocytopenia |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Vision Blurred |
3.0% |
| Contusion |
2.9% |
| Pneumonia |
2.9% |
| Pulmonary Embolism |
2.9% |
| Renal Impairment |
2.9% |
| Urinary Retention |
2.9% |
| Myositis |
2.7% |
| Suicidal Ideation |
2.7% |
|
| Interacting |
| Urinary Tract Infection |
25.2% |
| Product Used For Unknown Indication |
20.9% |
| Cardiac Failure Congestive |
12.9% |
| Drug Use For Unknown Indication |
10.1% |
| Atrial Fibrillation |
4.3% |
| Staphylococcal Infection |
4.3% |
| Pulmonary Embolism |
3.6% |
| Type 2 Diabetes Mellitus |
2.9% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Dementia Alzheimer's Type |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hypertension |
1.4% |
| Prophylaxis Urinary Tract Infection |
1.4% |
| Restless Legs Syndrome |
1.4% |
| Anaemia |
0.7% |
| Citrobacter Infection |
0.7% |
| Convulsion |
0.7% |
| Deep Vein Thrombosis |
0.7% |
| Delirium |
0.7% |
|
| Urinary Tract Infection |
14.7% |
| Drug Interaction |
11.8% |
| Hypoglycaemia |
11.8% |
| Hyponatraemia |
8.8% |
| Myoclonus |
5.9% |
| Pancytopenia |
5.9% |
| Renal Impairment |
5.9% |
| Blood Creatinine Increased |
2.9% |
| Blood Potassium Decreased |
2.9% |
| Blood Urea Decreased |
2.9% |
| Confusional State |
2.9% |
| Hyperkalaemia |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Nausea |
2.9% |
| Nephropathy Toxic |
2.9% |
| Retroperitoneal Haematoma |
2.9% |
| Rhabdomyolysis |
2.9% |
| Ureteric Obstruction |
2.9% |
| White Blood Cell Count Increased |
2.9% |
|
